Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues
Nucleos(t)ide analogues(NA) are a breakthrough in the treatment and management of chronic hepatitis B.NA could suppress the replication of hepatitis B virus(HBV) and control the progression of the disease.However,drug resistance caused by their long-term use becomes a practical problem,which influen...
Saved in:
Published in | 世界胃肠病学杂志:英文版 Vol. 18; no. 48; pp. 7149 - 7157 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Nucleos(t)ide analogues(NA) are a breakthrough in the treatment and management of chronic hepatitis B.NA could suppress the replication of hepatitis B virus(HBV) and control the progression of the disease.However,drug resistance caused by their long-term use becomes a practical problem,which influences the long-term outcomes in patients.Liver transplantation is the only choice for patients with HBV-related end-stage liver disease.But,the recurrence of HBV after transplantation often caused by the development of drug resistance leads to unfavorable outcomes for the recipients.Recently,the multi-drug resistance(MDR) has become a common issue raised due to the development and clinical application of a variety of NA.This may complicate the antiviral therapy and bring poorly prognostic outcomes.Although clinical evidence has suggested that combination therapy with different NA could effectively reduce the viral load in patients with MDR,the advent of new antiviral agents with high potency and high genetic barrier to resistance brings hope to antiviral therapy.The future of HBV researches relies on how toprevent the MDR occurrence and develop reasonable and effective treatment strategies.This review focuses on the diagnostic and therapeutic progress in MDR caused by the anti-HBV NA and describes some new research progress in this field. |
---|---|
AbstractList | Nucleos(t)ide analogues(NA) are a breakthrough in the treatment and management of chronic hepatitis B.NA could suppress the replication of hepatitis B virus(HBV) and control the progression of the disease.However,drug resistance caused by their long-term use becomes a practical problem,which influences the long-term outcomes in patients.Liver transplantation is the only choice for patients with HBV-related end-stage liver disease.But,the recurrence of HBV after transplantation often caused by the development of drug resistance leads to unfavorable outcomes for the recipients.Recently,the multi-drug resistance(MDR) has become a common issue raised due to the development and clinical application of a variety of NA.This may complicate the antiviral therapy and bring poorly prognostic outcomes.Although clinical evidence has suggested that combination therapy with different NA could effectively reduce the viral load in patients with MDR,the advent of new antiviral agents with high potency and high genetic barrier to resistance brings hope to antiviral therapy.The future of HBV researches relies on how toprevent the MDR occurrence and develop reasonable and effective treatment strategies.This review focuses on the diagnostic and therapeutic progress in MDR caused by the anti-HBV NA and describes some new research progress in this field. |
Author | Zhuo-Lun Song Yu-Jun Cui Wei-Ping Zheng Da-Hong Teng Hong Zheng |
AuthorAffiliation | Organ Transplant Center, The First CenterClinical College, Tianjin Medical University, Tianjin 300192,China Organ Transplant Center, Tianjin First Center Hospital, Tianjin300192, China |
Author_xml | – sequence: 1 fullname: Zhuo-Lun Song Yu-Jun Cui Wei-Ping Zheng Da-Hong Teng Hong Zheng |
BookMark | eNqNi1sKwjAURIMoWB97iAsoxKSl-usLFyD-Smhv00hNam6CuAPdU_fULVjBBfg1nDkzEzI01sCARJwv1zFfJWxIoiVjWbwWPBuTCeKVMS5EyiNS7rRUxqLXOZWmoL4CJxsIX26cVQ4QqS3pLdRex4ULivaVRi9NDvShfdXfenPcnKkJeQ0Wu_blu_atC-iVrK0KgDMyKmWNMP_llCwO-9P2GOeVNequjbo0Tt-ke16SJBNJlqbin80Hl6FL4g |
ContentType | Journal Article |
DBID | 2RA 92L CQIGP W91 ~WA |
DatabaseName | 中文科技期刊数据库 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues |
EISSN | 2219-2840 |
EndPage | 7157 |
ExternalDocumentID | 44734755 |
GroupedDBID | --- 123 29R 2B. 2C~ 2RA 2WC 36B 53G 5VR 8WL 92F 92I 92L 93N 93R AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CQIGP CS3 CW9 DIK DU5 E3Z EBS EJD EMB F5P FA0 FRP GX1 HYE M~E OK1 P2P RNS RPM SV3 TCJ TGQ TR2 W91 WFFXF XSB ~WA |
ID | FETCH-chongqing_primary_447347553 |
ISSN | 1007-9327 |
IngestDate | Wed Feb 14 10:43:56 EST 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 48 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-chongqing_primary_447347553 |
Notes | 14-1219/R Nucleos(t)ide analogues(NA) are a breakthrough in the treatment and management of chronic hepatitis B.NA could suppress the replication of hepatitis B virus(HBV) and control the progression of the disease.However,drug resistance caused by their long-term use becomes a practical problem,which influences the long-term outcomes in patients.Liver transplantation is the only choice for patients with HBV-related end-stage liver disease.But,the recurrence of HBV after transplantation often caused by the development of drug resistance leads to unfavorable outcomes for the recipients.Recently,the multi-drug resistance(MDR) has become a common issue raised due to the development and clinical application of a variety of NA.This may complicate the antiviral therapy and bring poorly prognostic outcomes.Although clinical evidence has suggested that combination therapy with different NA could effectively reduce the viral load in patients with MDR,the advent of new antiviral agents with high potency and high genetic barrier to resistance brings hope to antiviral therapy.The future of HBV researches relies on how toprevent the MDR occurrence and develop reasonable and effective treatment strategies.This review focuses on the diagnostic and therapeutic progress in MDR caused by the anti-HBV NA and describes some new research progress in this field. Hepatitis B virus Multi-drug resistance Nucleos(t)ide analogues Gene mutation Liver transplantation |
ParticipantIDs | chongqing_primary_44734755 |
PublicationCentury | 2000 |
PublicationDate | 2012 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – year: 2012 text: 2012 |
PublicationDecade | 2010 |
PublicationTitle | 世界胃肠病学杂志:英文版 |
PublicationTitleAlternate | World Journal of Gastroenterology |
PublicationYear | 2012 |
SSID | ssj0023352 |
Score | 4.0735707 |
Snippet | Nucleos(t)ide analogues(NA) are a breakthrough in the treatment and management of chronic hepatitis B.NA could suppress the replication of hepatitis B... |
SourceID | chongqing |
SourceType | Publisher |
StartPage | 7149 |
SubjectTerms | 临床应用 抗HBV 抗病毒治疗 核苷 类似物 耐药性 肝炎病毒 诊断 |
Title | Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues |
URI | http://lib.cqvip.com/qk/84123X/201248/44734755.html |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnVzBTttAEF1FnHpBrQqitKBF6pyirXC89q6PduIoQoA4hBa4IDvekFycFuxLvwD-iX_iF5jx2o4PtAIkazWZXTtrz_POeHZmGPs-MNJzk8QTcjbAxnV8oYN0JhKF5nFqsjTzKTn55NSfnMujC--i13voRC2VRfpj9vfFvJL3SBV5KFfKkn2DZNuLIgNplC-2KGFsXyXjkY2Ta2qudnKpbNwVrWK0f05BgyK7LW_6yCKDkd7mOqsNeybRz35OdY1XdxCPIRqC1kVDBcuMdhisj-eua8tCLCHSEPgQKwg80EOINWiXDiIGEB5WXQq0B7EH4QhCHOxDMKJe5ERj6rX_FITVWRFETjXGB63odB2AbuNtrxblShyXOYX43PQvS3GE9LBc9n-ZpTgjt8fVwmA7SsSERkzpR0VV_K6Pw-k4PCmIQ6CNaZWyqXgDXGUFqtXDl1fxsineWa_JyrFFUWv9rhxPrZVfG5IopXKl8qhcARUcavw-9ac7ZaZV--b1bKgSxwIn_wdvrGOPTD-yzfpDgocWFZ9Yz-Sf2XyNCI6I4B1E8AYRfDXna0TwNSI4IYI3iOA1Ip4e74unxwdEAW9RsMUOxvF0OBHt7K5_26ol180NuttsI1_lZodxtGAy4wQ6nZuZRHWTpI5v3Dka_SlZkvIL2_33dXb_1_mVfSA5Wl_VN7ZR3JZmD623It2vHuwzODFF7Q |
link.rule.ids | 315,786,790,4043 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+and+therapeutic+progress+of+multi-drug+resistance+with+anti-HBV+nucleos%EF%BC%88t%EF%BC%89ide+analogues&rft.jtitle=%E4%B8%96%E7%95%8C%E8%83%83%E8%82%A0%E7%97%85%E5%AD%A6%E6%9D%82%E5%BF%97%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88&rft.au=Zhuo-Lun+Song+Yu-Jun+Cui+Wei-Ping+Zheng+Da-Hong+Teng+Hong+Zheng&rft.date=2012&rft.issn=1007-9327&rft.eissn=2219-2840&rft.volume=18&rft.issue=48&rft.spage=7149&rft.epage=7157&rft.externalDocID=44734755 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg |